Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Natural Health Trends (NHTC) Common Equity (2016 - 2026)

Natural Health Trends (NHTC) has disclosed Common Equity for 17 consecutive years, with $16.5 million as the latest value for Q1 2026.

  • For Q1 2026, Common Equity fell 46.69% year-over-year to $16.5 million; the TTM value through Mar 2026 reached $16.5 million, down 46.69%, while the annual FY2025 figure was $23.4 million, 28.73% down from the prior year.
  • Common Equity hit $16.5 million in Q1 2026 for Natural Health Trends, down from $23.4 million in the prior quarter.
  • Across five years, Common Equity topped out at $56.9 million in Q1 2022 and bottomed at $16.5 million in Q1 2026.
  • Average Common Equity over 5 years is $39.0 million, with a median of $39.4 million recorded in 2024.
  • Year-over-year, Common Equity fell 13.01% in 2022 and then crashed 46.69% in 2026.
  • Natural Health Trends' Common Equity stood at $50.2 million in 2022, then fell by 17.05% to $41.6 million in 2023, then decreased by 20.98% to $32.9 million in 2024, then decreased by 28.73% to $23.4 million in 2025, then dropped by 29.73% to $16.5 million in 2026.
  • According to Business Quant data, Common Equity over the past three periods came in at $16.5 million, $23.4 million, and $26.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.